Gulf International Bank (UK) Ltd - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
Gulf International Bank (UK) Ltd ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$2,290,000
+46.5%
98,3230.0%0.03%
+45.0%
Q1 2018$1,563,000
-24.2%
98,323
-0.6%
0.02%
-23.1%
Q4 2017$2,061,000
+45.3%
98,9230.0%0.03%
+36.8%
Q3 2017$1,418,000
-17.0%
98,923
+0.6%
0.02%
-20.8%
Q2 2017$1,709,000
+57.7%
98,3230.0%0.02%
+50.0%
Q1 2017$1,084,000
-42.7%
98,323
+1.1%
0.02%
-44.8%
Q4 2016$1,892,000
-20.6%
97,2230.0%0.03%
-25.6%
Q3 2016$2,384,000
+22.2%
97,2230.0%0.04%
+18.2%
Q2 2016$1,951,000
-41.1%
97,2230.0%0.03%
-41.1%
Q1 2016$3,310,000
-66.5%
97,2230.0%0.06%
-67.4%
Q4 2015$9,883,000
-41.5%
97,223
+2.3%
0.17%
-45.7%
Q3 2015$16,890,000
-33.7%
94,993
+3.5%
0.32%
-28.4%
Q2 2015$25,461,000
+40.9%
91,763
+0.2%
0.44%
+37.6%
Q1 2015$18,075,000
+18.8%
91,583
+0.1%
0.32%
+19.3%
Q4 2014$15,213,000
+3.2%
91,463
+2.1%
0.27%
-1.1%
Q3 2014$14,736,000
+15.7%
89,587
+1.3%
0.27%
+16.2%
Q2 2014$12,731,000
-0.4%
88,454
+0.7%
0.24%
-5.6%
Q1 2014$12,777,000
+16.7%
87,8540.0%0.25%
+14.2%
Q4 2013$10,948,00087,8540.22%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2016
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,577,892$994,984,00031.62%
Ruane, Cunniff & Goldfarb 33,922,192$6,051,041,00031.06%
LeVasseur Capital Partners LLC 162,394$28,968,00029.76%
FARLEY CAPITAL L.P. 192,130$34,272,00027.18%
Pershing Square Capital Management 19,473,933$3,473,760,00024.90%
Arrow Capital Management, LLC 109,461$19,525,00016.53%
Marble Arch Investments 1,196,900$213,503,00016.43%
Tesuji Partners 1,368,040$244,414,00015.82%
ValueAct Holdings 14,994,261$2,674,676,00015.55%
Hound Partners 3,898,648$695,441,00015.04%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders